ஏட்ரியல் குறு நடுக்கம் நோயாளிகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஏட்ரியல் குறு நடுக்கம் நோயாளிகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஏட்ரியல் குறு நடுக்கம் நோயாளிகள் Today - Breaking & Trending Today

Huma raises $130 million financing to scale its digital health platform for better care and research


LONDON and NEW YORK
 , May 12, 2021 /PRNewswire/  Huma Therapeutics Limited today announces the completion of its latest funding round with financing of approximately $130 million. The investment will scale Huma s modular platform which can power digital hospitals at home nationally, and support the pharmaceutical and research industries to run the largest ever decentralized clinical trials. Huma s platform combines predictive algorithms, digital biomarkers and real-world data to advance proactive care and research.
Leaps by Bayer and Hitachi Ventures led the Series C funding round, which also saw new strategic and financial investors become shareholders. Samsung Next, Sony Innovation Fund by IGV , Unilever Ventures and HAT Technology & Innovation Fund by HAT, as well as individuals Nikesh Arora (former president of SoftBank) and Michael Diekmann (Chairman of Allianz) are also new shareholders. ....

United Kingdom , City Of , Jonathan Machado , Dan Vahdat , Alan Milburn , Keiji Kojima , Michael Diekmann , Ignazio Castiglioni , Juergen Eckhardt , Gen Tsuchikawa , Claudia Suessmuth Dyckerhoff , Nikesh Arora , Huma Therapeutics , World Economic Forum Global Innovators Community , Innovation Growth Ventures Co Ltd , Daiwa Capital Holdings , Prudential Regulation Authority , United Kingdom Health , University Of Cambridge , Goldman Sachs International , Stanford University Center , Technology Innovation Fund , Sony Innovation Fund , Financial Conduct Authority , Johns Hopkins Bloomberg School Of Public Health , Formative Research ,

Acutus Medical Initiates First IDE Therapy Trial With AcQBlate Force Sensing Ablation System


Acutus Medical Initiates First IDE Therapy Trial With AcQBlate Force Sensing Ablation System
The Acutus Medical AcQBlate Force sensing ablation catheter.
April 5, 2021 Acutus Medical today announced initial U.S. enrollments in the company’s AcQForce Flutter Investigational Device Exemption (IDE) clinical trial. This trial is expected to enroll up to 150 subjects in leading centers globally and will evaluate the safety and efficacy of the AcQBlate Force sensing ablation catheter and system in the treatment of right atrial typical flutter. 
In the U.S., right atrial typical flutter ablation procedures currently account for approximately 30% of cardiac ablations and are expected to reach 200,000 annually by 2025.[1] ....

United States , Hugh Calkins , Sean Beinart , Andrew Krahn , Oussama Wazni , Vince Burgess , Acqblate Force Sensing Catheter , Adventist Healthcare White Oak Medical Center , Ep Ablation Technology , Baptist Health Medical Group In Lexington , Acutu Acqblate , Acutus Medical , Flutter Investigational Device Exemption , Qubic Force , Gery Tomassoni , Baptist Health Medical Group , Silver Springs , Force Sensing Catheter , Technology Content , Early Ablation Improved Outcomes , Atrial Fibrillation Patients , Top New , Heart Rhythm Society , Current State , Atrial Fibrillation Ablation Technologies , ஒன்றுபட்டது மாநிலங்களில் ,